Hidden Industrial Trans-Fatty Acids: Mechanistic Insights into Dyslipidemia, Cardiovascular Disease, and Metabolic Dysfunction-Associated Steatotic Liver Disease
International Journal of Molecular Sciences · 03.12.2025 · 26 (23) · 11715
DOI: 10.3390/ijms262311715 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.12.2025. Verfasst von Mona A Hegazy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Faculty of Medicine, Cairo University, Cairo 12556, Egypt. Hauptthemen laut MEDLINE: Trans Fatty Acids, Dyslipidemias, Cardiovascular Diseases, Fatty Liver. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Trans-fatty acids (TFAs), particularly industrially produced TFAs (iTFAs), are linked to dyslipidemia, cardiovascular disease (CVD), and metabolic dysfunction-associated steatotic liver disease (MASLD). Despite regulatory efforts, “hidden” TFAs persist in processed foods, posing ongoing health risks. This narrative review synthesizes evidence on the biochemical and metabolic impacts of the most studied TFAs, focusing on dyslipidemia, CVD, and MASLD, and highlights gaps in research and policy. Available data suggest that iTFAs, which are dominant in modern diets, were associated with elevated low-density lipoprotein cholesterol (LDL-C), triglycerides, and lipoprotein (a), reduced high-density lipoprotein cholesterol (HDL-C), exacerbating atherosclerosis, increasing hepatic lipogenesis, oxidative stress, and inflammation and driving MASLD progression to fibrosis, whereas ruminant TFAs (rTFAs) showed neutral or beneficial effects. Epigenetic modifications (e.g., DNA methylation, miRNA alterations) induced by TFAs may further worsen metabolic dysfunction. Analytical challenges and inconsistent food labeling make it difficult to assess TFAs intake. Global disparities in TFAs regulations persist, but some regions still exceed recommended limits. Hidden iTFAs represent a critical public health issue, necessitating stricter policies, improved labeling, and consumer education. Future research should prioritize human studies on TFA-induced epigenetic changes and develop healthier fat alternatives. Eliminating residual iTFAs from the food supply is essential to mitigate cardiometabolic risks globally.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Faculty of Medicine, Cairo University, Cairo 12556, Egypt.
- Department of Bromatology, University of Belgrade-Faculty of Pharmacy, 11000 Belgrade, Serbia.
- Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo 12556, Egypt.
- Department of Medical Biochemistry, University of Belgrade-Faculty of Pharmacy, 11000 Belgrade, Serbia.
ORCID-Profile: Bojana Vidovic, Aleksandra Zeljkovic, Aleksandra Stefanovic
Zitieren
APA
Hegazy, M. A., Vidovic, B., Abobakr, S., Zeljkovic, A., Stefanovic, A., & Vekic, J. (2025). Hidden Industrial Trans-Fatty Acids: Mechanistic Insights into Dyslipidemia, Cardiovascular Disease, and Metabolic Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences, 26(23), 11715. https://doi.org/10.3390/ijms262311715
Vancouver
Hegazy MA, Vidovic B, Abobakr S, Zeljkovic A, Stefanovic A, Vekic J. Hidden Industrial Trans-Fatty Acids: Mechanistic Insights into Dyslipidemia, Cardiovascular Disease, and Metabolic Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences. 2025;26(23):11715. doi:10.3390/ijms262311715
BibTeX
@article{Hegazy2025,
author = {Hegazy, Mona A and Vidovic, Bojana and Abobakr, Shimaa and Zeljkovic, Aleksandra and Stefanovic, Aleksandra and Vekic, Jelena},
title = {Hidden Industrial Trans-Fatty Acids: Mechanistic Insights into Dyslipidemia, Cardiovascular Disease, and Metabolic Dysfunction-Associated Steatotic Liver Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {23},
pages = {11715},
doi = {10.3390/ijms262311715}
}
EUVIMED